REOPRO Side Effects

6578619-1 | Shock Haemorrhagic
on Feb 02, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: shock haemorrhagic. Reopro dosage: 12:30 To 18:45. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6578104-7 | Cerebrovascular Accident, Hypercoagulation
Patient was taking Reopro (View Usage). Patient had the following side effects: cerebrovascular accident, hypercoagulation on Feb 01, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with myocardial infarction and. Reopro dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6577414-7 | Pharyngeal Haemorrhage, Pneumonia, Thrombosis In Device
Adverse event was reported on Feb 02, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: AUSTRIA , 50 years of age, After Reopro was administered, patient had the following side effects: pharyngeal haemorrhage, pneumonia (What is pneumonia?), thrombosis in device. During the same period patient was treated with HEPARIN (60 Iu/kg) (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6573645-0 | Cardio-respiratory Arrest, Thrombosis, Thrombosis In Device
on Jan 30, 2010 Male patient from INDIA , 70 years of age, was diagnosed with coronary angioplasty and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, thrombosis, thrombosis in device. Reopro dosage: . During the same period patient was treated with EPTIFIBATIDE (View Eptifibatide Review and Eptifibatide Label ). Patient was hospitalized.


6558290-5 | Pulmonary Haemorrhage, Respiratory Failure
on Jan 22, 2010 Male patient from SWEDEN , 56 years of age, was diagnosed with myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: pulmonary haemorrhage, respiratory failure. Reopro dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLEXANE (View Clexane Review and Clexane Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6558288-7 | Cardiogenic Shock, Haematuria, Haemoptysis, Pulmonary Alveolar Haemorrhage, Renal Failure, Thrombocytopenia
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: cardiogenic shock, haematuria, haemoptysis, pulmonary alveolar haemorrhage, renal failure, thrombocytopenia on Jan 20, 2010 from FRANCE Additional patient health information: Male patient , 88 years of age, was diagnosed with myocardial ischaemia and. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6547225-7 | Hypercoagulation
Adverse event was reported on Jan 13, 2010 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: hypercoagulation.

6547224-5 | Cardiac Arrest
on Jan 15, 2010 Male patient from GERMANY , 70 years of age, was treated with Reopro (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Reopro dosage: From 04-oct-2009 @20:43- 05-oct-2009 @11:00.

6544593-7 | Hip Fracture, Subarachnoid Haemorrhage
on Jan 12, 2010 Female patient from GERMANY , 87 years of age, was diagnosed with myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: hip fracture, subarachnoid haemorrhage. Reopro dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6541536-7 | Ventricular Fibrillation
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular fibrillation on Jan 08, 2010 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with acute myocardial infarction and. Reopro dosage: .

6539402-6 | Cardiogenic Shock, Electromechanical Dissociation, Myocardial Ischaemia, Pericardial Effusion
Adverse event was reported on Jan 08, 2010 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: GERMANY , 75 years of age, Patient had the following side effects: cardiogenic shock, electromechanical dissociation, myocardial ischaemia, pericardial effusion.

6527805-5 | Cardiac Tamponade, Urinary Bladder Haemorrhage
on Dec 28, 2009 Male patient from GERMANY , 68 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: cardiac tamponade, urinary bladder haemorrhage. Reopro dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6518903-0 | Cerebral Haemorrhage
on Dec 17, 2009 Female patient from AUSTRIA , 75 years of age, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Reopro dosage: Infused 4-5 Hours. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized and became disabled.

6515772-X | Cardiac Arrest, Ventricular Tachycardia
Patient was taking Reopro (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular tachycardia on Dec 16, 2009 from INDIA Additional patient health information: Male patient , 68 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?) and. Reopro dosage: . Patient was hospitalized.

6493578-8 | Cerebral Haemorrhage
Adverse event was reported on Dec 08, 2009 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with angioplasty (What is angioplasty?) and. Location: INDIA , 65 years of age, After Reopro was administered, patient had the following side effects: cerebral haemorrhage. Patient was hospitalized.

6476844-1 | Thrombosis In Device
on Nov 27, 2009 Male patient from INDIA , 34 years of age, was diagnosed with coronary angioplasty and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis in device. Reopro dosage: . Patient was hospitalized.

6437391-6 | Cardiac Arrest
on Nov 04, 2009 Male patient from INDIA , 55 years of age, was diagnosed with coronary angioplasty and was treated with Reopro (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Reopro dosage: . Patient was hospitalized.

6434305-X | Gastrointestinal Haemorrhage
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: gastrointestinal haemorrhage on Nov 02, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 83 years of age, was diagnosed with thrombosis and. Reopro dosage: .

6420042-4 | Pulmonary Alveolar Haemorrhage
Adverse event was reported on Oct 22, 2009 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage.

6408111-6 | Thrombosis In Device
on Oct 14, 2009 Male patient from INDIA , 34 years of age, was diagnosed with coronary angioplasty and was treated with Reopro (View Usage). Patient had the following side effects: thrombosis in device. Reopro dosage: . Patient was hospitalized.

6408110-4 | Thrombosis In Device
on Oct 10, 2009 Male patient from INDIA , 43 years of age, was diagnosed with angina unstable and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: thrombosis in device. Reopro dosage: . Patient was hospitalized.

6404928-2 | Coronary Artery Thrombosis, Overdose, Puncture Site Haemorrhage, Subdural Haemorrhage
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery thrombosis, overdose, puncture site haemorrhage, subdural haemorrhage on Oct 07, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, was diagnosed with angina pectoris, angioplasty (What is angioplasty?) and. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN SODIUM (3000 Df) (View Heparin Sodium Review and Heparin Sodium Label ), BETA BLOCKERS, NOS (View Beta Blockers, Nos Review and Beta Blockers, Nos Label ). Patient was hospitalized.

6403623-3 | Puncture Site Haemorrhage, Thrombocytopenia, Vessel Puncture Site Haematoma
Adverse event was reported on Oct 06, 2009 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with thrombosis in device and. Location: FRANCE , 46 years of age, Patient had the following side effects: puncture site haemorrhage, thrombocytopenia, vessel puncture site haematoma. During the same period patient was treated with DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ), NEXIUM (View Nexium Review and Nexium Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

6401878-2 | Coronary Artery Thrombosis
on Oct 06, 2009 Female patient from GERMANY , 69 years of age, was diagnosed with percutaneous coronary intervention, acute myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: coronary artery thrombosis. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6401877-0 | Condition Aggravated, Gastrointestinal Haemorrhage
on Oct 09, 2009 Male patient from INDIA , 40 years of age, was diagnosed with coronary angioplasty and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gastrointestinal haemorrhage. Reopro dosage: . Patient was hospitalized.

6394682-5 | Conjunctival Haemorrhage, Pulmonary Congestion, Thrombocytopenia
Patient was taking Reopro (View Usage). Patient had the following side effects: conjunctival haemorrhage, pulmonary congestion, thrombocytopenia on Sep 29, 2009 from SPAIN Additional patient health information: Male patient , 44 years of age, was diagnosed with acute myocardial infarction, percutaneous coronary intervention and. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), IODIXANOL (View Iodixanol Review and Iodixanol Label ), TROMETAMOL (View Trometamol Review and Trometamol Label ).

6391129-X | Coronary Artery Thrombosis, Puncture Site Haemorrhage, Subdural Haemorrhage
Adverse event was reported on Sep 29, 2009 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with angina pectoris, angioplasty (What is angioplasty?) and. Location: UNITED KINGDOM , 61 years of age, After Reopro was administered, patient had the following side effects: coronary artery thrombosis, puncture site haemorrhage, subdural haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN SODIUM (3000 Df) (View Heparin Sodium Review and Heparin Sodium Label ), BETA BLOCKERS, NOS (View Beta Blockers, Nos Review and Beta Blockers, Nos Label ). Patient was hospitalized.

6381832-X | Pulmonary Alveolar Haemorrhage
on Sep 23, 2009 Female patient from PORTUGAL , 66 years of age, was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage. Reopro dosage: .

6381831-8 | Chills, Platelet Count Decreased
on Sep 23, 2009 Male patient from AUSTRIA , 49 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction, prophylaxis and was treated with Reopro (View Usage). Patient had the following side effects: chills, platelet count decreased. Reopro dosage: . During the same period patient was treated with ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6370045-3 | Coronary Artery Thrombosis, Puncture Site Haemorrhage, Subdural Haemorrhage
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: coronary artery thrombosis, puncture site haemorrhage, subdural haemorrhage on Sep 18, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, was diagnosed with angina pectoris, angioplasty (What is angioplasty?) and. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN SODIUM (3000 Df) (View Heparin Sodium Review and Heparin Sodium Label ), BETA BLOCKERS, NOS (View Beta Blockers, Nos Review and Beta Blockers, Nos Label ). Patient was hospitalized.

6369574-8 | Hospitalisation, Pulmonary Alveolar Haemorrhage
Adverse event was reported on Sep 17, 2009 by a Female patient taking Reopro (View Usage) (Dosage: ) . Location: PORTUGAL , 66 years of age, Patient experienced the following unwanted or unexpected effects: hospitalisation, pulmonary alveolar haemorrhage. Patient was hospitalized.

6355468-0 | Platelet Count Abnormal, Thrombosis In Device
on Sep 03, 2009 Male patient from UNITED STATES , 69 years of age, was diagnosed with percutaneous coronary intervention and was treated with Reopro (View Usage). Patient had the following side effects: platelet count abnormal, thrombosis in device. Reopro dosage: . Patient was hospitalized.

6341859-0 | Atrial Flutter, Pneumonia, Renal Failure Acute
on Aug 27, 2009 Female patient from GERMANY , 72 years of age, was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: atrial flutter, pneumonia (What is pneumonia?), renal failure acute. Reopro dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), CORVATON (View Corvaton Review and Corvaton Label ).

6341299-4 | Chills, Platelet Count Decreased
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: chills, platelet count decreased on Aug 26, 2009 from AUSTRIA Additional patient health information: Male patient , 49 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction, prophylaxis and. Reopro dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6335139-7 | Platelet Count Decreased
Adverse event was reported on Aug 20, 2009 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with thrombotic microangiopathy and. Location: UNITED STATES , weighting 220.5 lb, Patient had the following side effects: platelet count decreased. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6328649-X | Atrial Fibrillation, Platelet Count Decreased
on Aug 18, 2009 Male patient from UNITED STATES , weighting 160.9 lb, was diagnosed with myocardial infarction and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), platelet count decreased. Reopro dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6314359-1 | Accidental Overdose
on Aug 10, 2009 Male patient from UNITED STATES , weighting 215.0 lb, was diagnosed with percutaneous coronary intervention and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose. Reopro dosage: 9mg/250cc.

6304548-4 | Angina Pectoris
Patient was taking Reopro (View Usage). Patient had the following side effects: angina pectoris on Aug 03, 2009 from GERMANY Additional patient health information: Female patient , 74 years of age, was diagnosed with acute myocardial infarction and. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).

6302826-6 | Chest Pain, Dyspnoea, Faeces Discoloured, Gastrointestinal Haemorrhage, Haemoglobin Decreased
Adverse event was reported on Jul 31, 2009 by a Female patient taking Reopro (View Usage) (Dosage: ) was diagnosed with percutaneous coronary intervention, stent placement and. Location: UNITED KINGDOM , 80 years of age, After Reopro was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, faeces discoloured, gastrointestinal haemorrhage, haemoglobin decreased. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6285878-1 | Platelet Count Decreased
on Jul 21, 2009 Male patient from UNITED STATES , 50 years of age, was diagnosed with thrombotic microangiopathy and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6284407-6 | Cerebral Haemorrhage
on Jul 20, 2009 Female patient from GERMANY , 68 years of age, was diagnosed with arteriogram coronary, myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: cerebral haemorrhage. Reopro dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).

6284406-4 | Cardiogenic Shock
Patient was taking Reopro (View Usage). After Reopro was administered, patient had the following side effects: cardiogenic shock on Jul 21, 2009 from INDIA Additional patient health information: Male patient , 65 years of age, was diagnosed with percutaneous coronary intervention and. Reopro dosage: . Patient was hospitalized.

6284405-2 | Accidental Overdose
Adverse event was reported on Jul 16, 2009 by a Male patient taking Reopro (View Usage) (Dosage: 9mg/250cc) was diagnosed with percutaneous coronary intervention and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose.

6272185-6 | Angina Pectoris
on Jul 09, 2009 Female patient from GERMANY , 74 years of age, was diagnosed with acute myocardial infarction and was treated with Reopro (View Usage). Patient had the following side effects: angina pectoris. Reopro dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).

6272184-4 | Underdose
on Jul 07, 2009 Male patient from UNITED STATES , 65 years of age, weighting 264.6 lb, was diagnosed with acute coronary syndrome and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: underdose. Reopro dosage: .

6252451-0 | Cardiac Failure, Pulmonary Haemorrhage, Respiratory Failure
Patient was taking Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, pulmonary haemorrhage, respiratory failure on Jun 22, 2009 from UNITED STATES Additional patient health information: Male patient , 71 years of age, . Reopro dosage: .

6246268-0 | Myocardial Infarction, Thrombocytopenia
Adverse event was reported on Jun 16, 2009 by a Male patient taking Reopro (View Usage) (Dosage: ) was diagnosed with stent placement, myocardial infarction and. Location: NETHERLANDS , weighting 198.4 lb, Patient had the following side effects: myocardial infarction, thrombocytopenia. During the same period patient was treated with ASCAL (View Ascal Review and Ascal Label ), PLAVIX (View Plavix Review and Plavix Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), HEPARIN (View Heparin Review and Heparin Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

6232304-4 | Cardiac Arrest, Coronary Artery Occlusion
on Jun 09, 2009 Female patient from UNITED STATES , 56 years of age, was diagnosed with coronary artery occlusion and was treated with Reopro (View Usage). After Reopro was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), coronary artery occlusion. Reopro dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6229345-X | Cardiac Arrest, Coronary Artery Occlusion
on Jun 05, 2009 Female patient from UNITED STATES , 56 years of age, was diagnosed with coronary artery occlusion and was treated with Reopro (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), coronary artery occlusion. Reopro dosage: .

6210610-7 | Cardio-respiratory Arrest, Depressed Level Of Consciousness, Post Procedural Complication, Somnolence
Patient was taking Reopro (View Usage). Patient had the following side effects: cardio-respiratory arrest, depressed level of consciousness, post procedural complication, somnolence on May 29, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 165.3 lb, was diagnosed with coronary angioplasty, coronary artery disease (What is coronary artery disease?) and. Reopro dosage: See Image.